T. Trippenbach et N. Lake, EXCITATORY CARDIOVASCULAR AND RESPIRATORY EFFECTS OF BACLOFEN IN INTACT RATS, Canadian journal of physiology and pharmacology, 72(10), 1994, pp. 1200-1207
The rat has become the preferred animal model for study of the central
control of the cardiorespiratory system. However, data in the literat
ure suggest that the role of GABA(B) receptors in control of the respi
ratory timing may be different in rats from that in other species. The
refore in this study we investigated cardiorespiratory effects of repe
ated injections of 0.5 nM baclofen and 50 nM CGP35348, GABA(B) recepto
r agonist and antagonist, respectively, applied into the fourth ventri
cle of urethane-anesthetized intact, spontaneously breathing Wistar ra
ts. Baclofen increased arterial blood pressure (ABP), heart rate, insp
iratory time (Ti), and the rate of rise (Di/t) and peak amplitude of t
he integrated diaphragmatic EMG (Di). Expiration (Te) was unaffected.
CGP35348 reversed the ABP and Di effects of baclofen and decreased Di/
t and Te below their control values, whereas Ti remained prolonged. Th
ese excitatory effects of baclofen are consistent with previously repo
rted effects of low i.v. doses of baclofen in cats, and suggest that G
ABA(B) receptors may modulate the depth and duration of inspiration. W
e conclude that the intact rat represents a suitable animal model for
investigations of the integrated control of cardiorespiratory function
s. To our knowledge this is the first investigation reporting excitato
ry effects of GABA(B) receptor stimulation on inspiratory activity in
rats. The depressant effects of baclofen on the respiratory rhythm rep
orted in the rat ''isolated'' brain in situ, and the neonatal rat brai
nstem - spinal cord in vitro seem to be unique for those specific prep
arations. Key